Recent Posts on This Topic | See All >
Drugmakers to share data to speed brain drug researchTags: c-path
[Source: Reuters] - Major drugmakers will share data from their clinical trials for Alzheimer's and Parkinson's disease in an effort to speed the development of new medicines to treat the brain disorders.
The database, a public/private partnership to be announced on Friday, will give academic and industry researchers worldwide access to information from more than 4,000 patients with neurodegenerative diseases.
Bringing the data together, rather than keeping pieces of it within each drug company, will give scientists a larger amount of information on how the diseases progress and how they differ in various patients.
For more information: Drugmakers to share data to speed brain drug research
Now available: “Action and Impact," a 2014 report on the grant programs and activities of the Flinn Foundation in Arizona biosciences, civic leadership, arts and culture, and the Flinn Scholars program.